We’re glad to see you’re enjoying ReachMD…but how about a more personalized experience?
Case: Peri-Operative Immunotherapy in Early-Stage NSCLC
Joshua E. Reuss, MD
Jessica S. Donington, MD, MSCR
Case Study: Managing Common Adverse Events Associated with Second-Line Treatment of ES-SCLC
Ticiana Leal, MD
Jacob Sands, MD
ES-SCLC: Sequencing Strategies in Previously Treated Patients
Case: Adjuvant Immunotherapy in Localized NSCLC
Keeping Pace in Lung Cancer - HER2: Unveiling New Horizons in NSCLC Treatment
Charu Aggarwal, MD, MPH
Advances in Minimally Invasive Screening for Lung Cancer: Breaking Data from Honolulu
Julie A. Barta, MD, ATSF
Peter J. Mazzone, MD, MPH, FCCP
Highlights from Singapore on Immunotherapies in Metastatic NSCLC
Patrick Forde, M.B.B.Ch.
Key NSCLC Data from Singapore and Madrid: Implications to Practice
Highlights from Singapore on Immunotherapies in Early-Stage NSCLC
Highlights from Madrid on Targeted Therapy for Advanced NSCLC
Highlights from Singapore on Targeted Therapies in NSCLC
Highlights from Madrid on Perioperative Immunotherapy in Early-Stage NSCLC
Treatment Options for Invasive Fungal Infections: Why They Don't Always Work
Thomas F. Patterson, MD, FACP, FIDSA
George Thompson III, MD, FIDSA
Invasive Fungal Infections: More Common Than You Think
Peter G. Pappas, MD, FACP
Current Standards and Future Opportunities for ADCs in Advanced/Metastatic Triple-Negative Breast Cancer
William J. Gradishar, MD
Javier Cortes, MD, PhD
Hope S. Rugo, MD, FASCO
Press cancel to remain on ReachMD. Press the link below or the continue button to keep going.
Stay current with the best on medical education